How much should you trust BetterHelp, Talkspace, Cerebral and other mental health start-ups touted by celebrities?

When Pat Paulson’s son told her he was feel­ing anx­ious and depressed at col­lege, Paul­son went through her Blue Cross Blue Shield provider direc­to­ry and start­ed call­ing men­tal health ther­a­pists. No providers in the Wis­con­sin city where her son’s uni­ver­si­ty is locat­ed had open­ings. So she bought a month­ly sub­scrip­tion to Bet­ter­Help, a Moun­tain View,…

Read More

Six guidelines to navigate the Aduhelm controversy and (hopefully) help patients with Mild Cognitive Impairment and early-stage Alzheimer’s Disease

The approval of a con­tro­ver­sial new drug for Alzheimer’s dis­ease, Aduhelm, is shin­ing a spot­light on mild cog­ni­tive impair­ment — prob­lems with mem­o­ry, atten­tion, lan­guage or oth­er cog­ni­tive tasks that exceed changes expect­ed with nor­mal aging. After ini­tial­ly indi­cat­ing that Aduhelm could be pre­scribed to any­one with demen­tia, the Food and Drug Admin­is­tra­tion now spec­i­fies that…

Read More

Buyer beware: The story of a pricey and “credentialled” program to end Alzheimer’s Disease

When her hus­band was diag­nosed with ear­­ly-stage Alzheimer’s dis­ease in 2015, Eliz­a­beth Pan was dev­as­tat­ed by the lack of options to slow his inevitable decline. But she was encour­aged when she dis­cov­ered the work of a UCLA neu­rol­o­gist, Dr. Dale Bre­desen, who offered a com­pre­hen­sive lifestyle man­age­ment pro­gram to halt or even reverse cog­ni­tive decline…

Read More